We are using C. elegans genetics to look for new genes involved in receptor-mediated endocytosis. We have isolated 23 mutants, in 11 complementation groups, defective in the endocytosis of YP170-GFP by oocytes. Some of these mutants are temperature sensitive lethals. We anticipate that our mutants will identify key components of the general endocytic machinery as well as gene products that specifically mediate yolk uptake. The most severe YP170-GFP uptake defective mutants identify a gene encoding a putative receptor for vitellogenins (yolk proteins) in the C. elegans oocyte. During the normal maturation of oocytes within the C. elegans germline yolk proteins (YPs), encoded by the vit genes and secreted by the intestine, are actively endocytosed from the psuedocoelomic space and stored within membrane bound compartments sometimes called yolk platelets. A
vit-2::gfp transgene, encoding YP170-GFP, has allowed us to visualize this process in vivo and study its properties by fluorescence microscopy. RNAi analysis in this genetic background allowed us to test the function of potential components of the C. elegans endocytic machinery identified by the genome project. This analysis indicates that YP170 endocytosis requires clathrin coated pit components (clathrin heavy chain, adaptins, dynamin) and regulators of endosomal function (
rab5,
rab7,
rab11), as expected from studies of lipoprotein uptake in other organisms. 	One complementation group, comprised of three alleles, appears to mutate T11F8.c, a partially sequenced member of the LRP family of lipoprotein and proteinase receptors. We are currently confirming this inference by transformation rescue and sequencing of mutant alleles. RNAi data by Bossinger et al. (1997 IWM Abstract 61) had previously indicated a possible role for T11F8.c in yolk uptake. Our results show that T11F8.c RNAi blocks YP170-GFP uptake. We are tentatively naming this gene
lrp-2, in anticipation of the complete genomic sequence which is in progress at the sequencing consortium (Many thanks to Bob Waterston and Stephanie Chissoe). Immunofluorescence experiments, using polyclonal antisera we produced against intracellular or extracellular LRP-2 fusion proteins, indicate that LRP-2 is an abundant plasma membrane protein expressed specifically in oocytes. Our putative
lrp-2 mutants all show an absence or mislocalization of LRP-2 in oocytes. 	We are currently engaged in a more detailed phenotypic analysis of endocytic defects in the other ten complementation groups identified in our genetic screen utilizing anti-LRP-2 antibodies and other specific antisera we have developed against general endocytic pathway components identified in our RNAi screen (see abstract by Y. Zhang et al.).